Get to the root of your digestive issues with gut-brain therapy techniques that help you self-manage your gut symptoms in just 6-weeks.
IBS, functional dyspepsia, functional constipation, and functional heartburn are now classified as gut-brain disorders - conditions driven by miscommunication between the gut and brain. The same gut-brain dysfunction also explains why many people with IBD continue to experience pain, constipation, or diarrhea even when their disease is in remission.
When the gut and brain fail to communicate properly, the body can misinterpret normal digestive processes as pain or discomfort. This heightened sensitivity, known as visceral hypersensitivity, can make the gut more reactive and contribute to gastrointestinal symptoms.
Nerva combines evidence-based gut-brain therapy techniques with real human support to help you self-manage symptoms, rebuild confidence, and get back to living fully.
The Nerva program was co-founded by Dr. Simone Peters, who ran a clinical trial with Monash University that found gut-brain therapy therapy worked just as well as the Low FODMAP diet in helping you participants well with and self-manage IBS.
Gut-brain therapy techniques targets the source of the problem: oversensitive nerves in the gut.
Gut-brain therapy techniques teaches you how to address this miscommunication between the gut and brain.
Gut-brain therapy techniques has been shown to help with constipation, diarrhea and mixed IBS.
Studies have shown gut-brain therapy techniques can help you achieve long-lasting IBS management.
Answer questions about you and your gut history to see if Nerva can work for you.
Daily gut-brain sessions, educational content, and goal oriented progress, tailored to your preferences.
Learn skills that can help you teach your brain to ignore false alarms from the gut triggered by food and stress.
Live the life you want, free from the control of digestive diseases.
.png)
Backed by 5+ studies including a randomized controlled trial.
9/10 members see meaningful progress in 4-6 weeks.
Learn skills focused on retraining the gut-brain axis.
Short daily sessions from the comfort of your home.
Official versions of AmiBroker are highly optimized for speed and stability. Cracked versions, however, are inherently unstable. They frequently freeze, crash, or fail to load data plugins. A software crash in the middle of a live market session can prevent you from managing an open position or exiting a losing trade. 4. No Access to Software Updates
Amibroker is a popular technical analysis software used by traders and investors to analyze and trade financial markets. The software offers a wide range of features and tools, including real-time data feeds, charting, and backtesting capabilities. However, some individuals may be tempted to use an Amibroker crack version, which is an unauthorized and pirated copy of the software. In this article, we will discuss the risks and consequences of using an Amibroker crack version and why it's essential to use a legitimate copy of the software.
Amibroker has established itself as one of the most powerful and flexible trading platforms available today, favored by retail traders and professional investors alike for its sophisticated charting capabilities, robust backtesting engine, and extensive customization options. However, when searching for this software online, many users encounter the tempting prospect of "Amibroker crack version" downloads that promise full functionality without the associated cost. Amibroker Crack Version
: You should have received an email with license information directly from Amibroker or an authorized reseller
Trading based on flawed calculations can result in massive, avoidable financial losses in the live market. 3. Frequent Crashes and Instability Official versions of AmiBroker are highly optimized for
The Risks of Using an AmiBroker Crack Version: Why It Costs More Than It Saves
Websites like TradingView or platforms like MetaTrader 4/5 offer robust charting, scripting languages (Pine Script, MQL), and historical data without cost. A software crash in the middle of a
The Soft Costs — why it matters beyond malware
If your AFL script throws an unhandled exception or your database corrupts, you cannot reach out to AmiBroker support.
If you're interested in using Amibroker, consider exploring legitimate options:
"Hi, it's Alex, one of the founders of Nerva alongside Chris and Dr. Simone Peters.
We designed Nerva to help people with gut-brain disorders get back to a happy, normal life, free of flare-up worries. We're so proud of the fact that we've already helped over 300,000 people live better. Yet, we understand Nerva may not work for some people which is why we have a 100% money back guarantee.
If you finish your 6-week program and think Nerva hasn't helped you manage your symptoms, simply email support for a full refund of the Nerva program."
- Alex Naoumidis, Co-Founder and Co-CEO, Mindset Health
Based on studies that helped 3 in 4 people manage their gut symptoms.
15 minutes a day for 6 weeks. Short and relaxing sessions that fit with your schedule.
Discover helpful and calming flare-up exercises, like our deep breathing techniques.
Listen anytime and anywhere (home, office, couch, you name it).
Learn about gut-brain disorders with a range of easy to understand in-app articles.
Say bye to bots. We have real Nerva team members ready to help!
.svg)
.svg)
1) Anderson, Ellen J. BNutSci, MDiet1,2; Peters, Simone L. BSc (Psychophysiology) (Hons), PhD1; Gibson, Peter R. MBBS(Hons), MD1,2; Halmos, Emma P. BNutDiet, PGradDipBSc, PhD1,2. Comparison of Digitally Delivered Gut-Directed Hypnotherapy Program With an Active Control for Irritable Bowel Syndrome. The American Journal of Gastroenterology 120(2):p 440-448, February 2025. | DOI: 10.14309/ajg.0000000000002921 2) Peters, S. L., Yao, C. K., Philpott, H., Yelland, G. W., Muir, J. G., & Gibson, P. R. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary pharmacology & therapeutics, 44(5), 447–459. https://doi.org/10.1111/apt.13706
